Development of a validated liquid chromatographic method for quantification of sorafenib tosylate in the presence of stress‐induced degradation products and in biological matrix employing analytical quality by design approach
Authors:
- 4 February 2018
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 32 (5) , e4169
Abstract
The current research work envisages an analytical quality by design‐enabled development of a simple, rapid, sensitive, specific, robust and cost‐effective stability‐indicating reversed‐phase high‐performance liquid chromatographic method for determining stress‐induced forced‐degradation products of sorafenib tosylate (SFN). An Ishikawa fishbone diagram was constructed to embark upon analytical target profile and critical analytical attributes, i.e. peak area, theoretical plates, retention time and peak tailing. Factor screening using Taguchi orthogonal arrays and quality risk assessment studies carried out using failure mode effect analysis aided the selection of critical method parameters, i.e. mobile phase ratio and flow rate potentially affecting the chosen critical analytical attributes. Systematic optimization using response surface methodology of the chosen critical method parameters was carried out employing a two‐factor–three‐level–13‐run, face‐centered cubic design. A method operable design region was earmarked providing optimum method performance using numerical and graphical optimization. The optimum method employed a mobile phase composition consisting of acetonitrile and water (containing orthophosphoric acid, pH 4.1) at 65:35 v/v at a flow rate of 0.8 mL/min with UV detection at 265 nm using a C18 column. Response surface methodology validation studies confirmed good efficiency and sensitivity of the developed method for analysis of SFN in mobile phase as well as in human plasma matrix. The forced degradation studies were conducted under different recommended stress conditions as per ICH Q1A (R2). Mass spectroscopy studies showed that SFN degrades in strongly acidic, alkaline and oxidative hydrolytic conditions at elevated temperature, while the drug was per se found to be photostable. Oxidative hydrolysis using 30% H2O2 showed maximum degradation with products at retention times of 3.35, 3.65, 4.20 and 5.67 min. The absence of any significant change in the retention time of SFN and degradation products, formed under different stress conditions, ratified selectivity and specificity of the systematically developed method.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology (No: DST/INSPIRE Fellowship/[IF150273])
This publication has 24 references indexed in Scilit:
- Application of quality by design elements for the development and optimization of an analytical method for protamine sulfateJournal of Pharmaceutical and Biomedical Analysis, 2012
- Quality by Design Compliant Analytical Method ValidationAnalytical Chemistry, 2011
- Methods for the determination of limit of detection and limit of quantitation of the analytical methodsChronicles of Young Scientists, 2011
- Introduction to hyphenated techniques and their applications in pharmacyPharmaceutical Methods, 2010
- Introduction to hyphenated techniques and their applications in pharmacyPharmaceutical Methods, 2010
- Quality by Design: Concepts for ANDAsThe AAPS Journal, 2008
- Ruggedness and robustness testingJournal of Chromatography A, 2007
- ICH guidance in practice: Validated stability-indicating HPLC method for simultaneous determination of ampicillin and cloxacillin in combination drug productsJournal of Pharmaceutical and Biomedical Analysis, 2007
- Reprioritization of failures in a system failure mode and effects analysis by decision making trial and evaluation laboratory techniqueReliability Engineering & System Safety, 2006
- Validation in pharmaceutical analysisJournal of Pharmaceutical and Biomedical Analysis, 2005